300434.SHE Sichuan Goldstone Orient New Material Equipment Co Ltd
- Market cap
- CNY 4.96B
- P/E
- 27.4x
- P/B
- 1.87x
- ROE
- 7.1%
- Dividend yield
- 0.58%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 300434.SHE undervalued?
Graham number300434.SHE trades 51.1% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Sichuan Goldstone Orient New Material Equipment Co Ltd fundamental analysis
No fundamental analysis for Sichuan Goldstone Orient New Material Equipment Co Ltd yet.
Sichuan Goldstone Orient New Material Equipment Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Sichuan Goldstone Orient New Material Equipment Co Ltd
Sichuan Goldstone Asia Pharmaceutical Inc. engages in the research, development, and sale of medicines and health products in China. The company offers over-the-counter drugs, prescription drugs, and health food/health supplements, as well as Chinese herbal active pharmaceutical ingredients and food addictives, and medical devices. It produces and sells plastic composite pipes, pipe fittings and equipment, as well as develops vacuum coating, industrial machinery, pipe fittin…
Full company profileSichuan Goldstone Orient New Material Equipment Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Sichuan Goldstone Orient New Material Equipment Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 162M | 704M | 971M | 1.01B | 777M | 1.05B | 1.24B | 1.21B | 1.10B | 1.04B | 947M |
| Gross Profit | 56.2M | 450M | 640M | 647M | 417M | 594M | 762M | 741M | 629M | 605M | 584M |
| Operating Income | 24.0M | 151M | 189M | 161M | -668M | 89.0M | 292M | 178M | 130M | 156M | 218M |
| EBITDA | 32.9M | 209M | 272M | 243M | -579M | 181M | 382M | 274M | 226M | 257M | 217M |
| Net Income | 25.5M | 116M | 149M | 120M | -688M | 66.5M | 219M | 126M | 91.8M | 132M | 189M |
| EPS | 0.11 | 0.37 | 0.37 | 0.30 | -1.71 | 0.17 | 0.54 | 0.31 | 0.23 | 0.33 | 0.47 |
| Balance Sheet | |||||||||||
| Total Assets | 484M | 3.13B | 3.19B | 3.23B | 2.49B | 2.77B | 3.06B | 3.10B | 3.05B | 3.23B | 3.19B |
| Total Liabilities | 80.7M | 575M | 508M | 456M | 435M | 606M | 757M | 677M | 585M | 651M | 512M |
| Shareholders' Equity | 402M | 2.52B | 2.64B | 2.73B | 2.02B | 2.08B | 2.27B | 2.40B | 2.45B | 2.55B | 2.66B |
| Cash & Short-term Investments | 69.0M | 193M | 343M | 338M | 484M | 289M | 504M | 588M | 431M | 307M | 348M |
| Total Debt | - | 73.0M | 25.0M | 8.00M | 10.0M | 980K | 10.3M | 113M | 76.2M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 25.2M | 173M | 199M | 186M | 133M | 136M | 323M | 151M | 158M | 208M | - |
| Capital Expenditure | 85.7M | 32.7M | 26.8M | 27.2M | 35.1M | 85.4M | 54.1M | 66.1M | 72.9M | 99.6M | 94.6M |
| Free Cash Flow | -60.6M | 140M | 172M | 159M | 97.9M | 51.0M | 269M | 85.0M | 85.2M | 108M | 155M |
| Ratios | |||||||||||
| ROE | 6.3% | 4.6% | 5.6% | 4.4% | -34.1% | 3.2% | 9.6% | 5.3% | 3.7% | 5.2% | 7.1% |
| ROA | 5.3% | 3.7% | 4.7% | 3.7% | -27.6% | 2.4% | 7.2% | 4.1% | 3.0% | 4.1% | 5.9% |
| Net Profit Margin | 15.7% | 16.5% | 15.4% | 12.0% | -88.5% | 6.3% | 17.6% | 10.4% | 8.3% | 12.7% | 19.9% |
| Debt to Equity | - | 0.03x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.05x | 0.03x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Sichuan Goldstone Orient New Material Equipment Co Ltd dividends
- Dividend yield
- 0.58%
- Forward dividend
- 0.08 CNY
- Payout ratio
- 21.8%
- Ex-dividend date
- Jun 17, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 28.7M | 0.07 | 21.8% |
| 2024 | CNY 45.2M | 0.11 | 49.3% |
| 2023 | CNY 741K | 0.00 | 0.6% |
| 2022 | CNY 113K | 0.00 | 0.1% |
| 2021 | CNY 325K | 0.00 | 0.5% |
| 2020 | CNY 27.6M | 0.07 | - |
| 2019 | CNY 32.1M | 0.08 | 26.7% |
| 2018 | CNY 26.9M | 0.07 | 18.0% |
| 2017 | CNY 16.6M | 0.05 | 14.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.8:1 on Oct 12, 2018.
Who owns Sichuan Goldstone Orient New Material Equipment Co Ltd
- Insiders 52.42%
- Institutions 1.77%
- Public & others 45.81%
- Shares outstanding 402M
- Free float 214M
Sichuan Goldstone Orient New Material Equipment Co Ltd company profile
- Company name
- Sichuan Goldstone Orient New Material Equipment Co Ltd
- Ticker
- 300434.SHE
- ISIN
- CNE100001YX5
- Exchange
- Shenzhen Stock Exchange
- Sector
- Industrials
- Industry
- Machinery
- Employees
- 1,794
- Fiscal year end
- December
- Address
- No. 4760 Jiangnan Avenue, Hangzhou, China, 610200
- Phone
- 86 28 8562 8208
- Website
- goldstone-group.com
About Sichuan Goldstone Orient New Material Equipment Co Ltd
Sichuan Goldstone Asia Pharmaceutical Inc. engages in the research, development, and sale of medicines and health products in China. The company offers over-the-counter drugs, prescription drugs, and health food/health supplements, as well as Chinese herbal active pharmaceutical ingredients and food addictives, and medical devices. It produces and sells plastic composite pipes, pipe fittings and equipment, as well as develops vacuum coating, industrial machinery, pipe fitting molds, construction equipment, and special equipment. The company produces, installs, and maintains special equipment. It also imports and exports spare parts, raw, and auxiliary materials. Sichuan Goldstone Asia Pharmaceutical Inc. was founded in 1962 and is based in Hangzhou, China.
Sichuan Goldstone Orient New Material Equipment Co Ltd management
5- Mr. Yiping MaChairman & GM · born 1971
- Mr. Qing Guo WangCFO & Accounting Supervisor · born 1975
- Mr. Qiang LinDeputy GM, Secretary of the Board & Director · born 1964
- Ms. Xiaoxia ShengDeputy GM & Director · born 1977
- Mr. Zhihao WangDeputy General Manager · born 1974